VanEck Pharmaceutical Etf Forecast - Triple Exponential Smoothing

PPH Etf  USD 90.23  0.01  0.01%   
The Triple Exponential Smoothing forecasted value of VanEck Pharmaceutical ETF on the next trading day is expected to be 90.40 with a mean absolute deviation of  0.45  and the sum of the absolute errors of 26.95. VanEck Etf Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast VanEck Pharmaceutical stock prices and determine the direction of VanEck Pharmaceutical ETF's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of VanEck Pharmaceutical's historical fundamentals, such as revenue growth or operating cash flow patterns.
Check out Historical Fundamental Analysis of VanEck Pharmaceutical to cross-verify your projections.
  

Open Interest Against 2024-06-21 VanEck Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast VanEck Pharmaceutical's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in VanEck Pharmaceutical's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for VanEck Pharmaceutical stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current VanEck Pharmaceutical's open interest, investors have to compare it to VanEck Pharmaceutical's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of VanEck Pharmaceutical is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in VanEck. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in VanEck Pharmaceutical cannot accurately predict what will happen the next trading day because, historically, etf markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the VanEck Pharmaceutical's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets VanEck Pharmaceutical's price structures and extracts relationships that further increase the generated results' accuracy.
Triple exponential smoothing for VanEck Pharmaceutical - also known as the Winters method - is a refinement of the popular double exponential smoothing model with the addition of periodicity (seasonality) component. Simple exponential smoothing technique works best with data where there are no trend or seasonality components to the data. When VanEck Pharmaceutical prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any trend in VanEck Pharmaceutical price movement. However, neither of these exponential smoothing models address any seasonality of VanEck Pharmaceutical ETF.

VanEck Pharmaceutical Triple Exponential Smoothing Price Forecast For the 19th of May

Given 90 days horizon, the Triple Exponential Smoothing forecasted value of VanEck Pharmaceutical ETF on the next trading day is expected to be 90.40 with a mean absolute deviation of 0.45, mean absolute percentage error of 0.30, and the sum of the absolute errors of 26.95.
Please note that although there have been many attempts to predict VanEck Etf prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that VanEck Pharmaceutical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

VanEck Pharmaceutical Etf Forecast Pattern

Backtest VanEck PharmaceuticalVanEck Pharmaceutical Price PredictionBuy or Sell Advice 

VanEck Pharmaceutical Forecasted Value

In the context of forecasting VanEck Pharmaceutical's Etf value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. VanEck Pharmaceutical's downside and upside margins for the forecasting period are 89.81 and 91.00, respectively. We have considered VanEck Pharmaceutical's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
90.23
90.40
Expected Value
91.00
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of VanEck Pharmaceutical etf data series using in forecasting. Note that when a statistical model is used to represent VanEck Pharmaceutical etf, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors 0.0396
MADMean absolute deviation0.4492
MAPEMean absolute percentage error0.0051
SAESum of the absolute errors26.9492
As with simple exponential smoothing, in triple exponential smoothing models past VanEck Pharmaceutical observations are given exponentially smaller weights as the observations get older. In other words, recent observations are given relatively more weight in forecasting than the older VanEck Pharmaceutical ETF observations.

Predictive Modules for VanEck Pharmaceutical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as VanEck Pharmaceutical ETF. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of VanEck Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
89.6490.2390.82
Details
Intrinsic
Valuation
LowRealHigh
89.0389.6299.25
Details
Bollinger
Band Projection (param)
LowMiddleHigh
84.1487.4890.82
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as VanEck Pharmaceutical. Your research has to be compared to or analyzed against VanEck Pharmaceutical's peers to derive any actionable benefits. When done correctly, VanEck Pharmaceutical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in VanEck Pharmaceutical ETF.

Other Forecasting Options for VanEck Pharmaceutical

For every potential investor in VanEck, whether a beginner or expert, VanEck Pharmaceutical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. VanEck Etf price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in VanEck. Basic forecasting techniques help filter out the noise by identifying VanEck Pharmaceutical's price trends.

VanEck Pharmaceutical Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with VanEck Pharmaceutical etf to make a market-neutral strategy. Peer analysis of VanEck Pharmaceutical could also be used in its relative valuation, which is a method of valuing VanEck Pharmaceutical by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

VanEck Pharmaceutical ETF Technical and Predictive Analytics

The etf market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of VanEck Pharmaceutical's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of VanEck Pharmaceutical's current price.

VanEck Pharmaceutical Market Strength Events

Market strength indicators help investors to evaluate how VanEck Pharmaceutical etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading VanEck Pharmaceutical shares will generate the highest return on investment. By undertsting and applying VanEck Pharmaceutical etf market strength indicators, traders can identify VanEck Pharmaceutical ETF entry and exit signals to maximize returns.

VanEck Pharmaceutical Risk Indicators

The analysis of VanEck Pharmaceutical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in VanEck Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting vaneck etf prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

When determining whether VanEck Pharmaceutical ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Pharmaceutical Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Pharmaceutical Etf:
Check out Historical Fundamental Analysis of VanEck Pharmaceutical to cross-verify your projections.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
The market value of VanEck Pharmaceutical ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is VanEck Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Pharmaceutical's market value can be influenced by many factors that don't directly affect VanEck Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.